SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-09-002068
Filing Date
2009-12-17
Accepted
2009-12-16 18:02:35
Documents
5
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT, 09/30/09 imyn_10q-093009.htm 10-Q 305831
2 CERTIFICATION CEO ex31-1.htm EX-31.1 20857
3 CERTIFICATION CFO ex31-2.htm EX-31.2 21459
4 CERTIFICATION CEO ex32-1.htm EX-32.1 7729
5 CERTIFICATION CFO ex32-2.htm EX-32.2 8322
  Complete submission text file 0001437749-09-002068.txt   365617
Mailing Address 4225 EXECUTIVE SQUARE SUITE 260 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 260 LA JOLLA CA 92037 858-200-2320
IMMUNOSYN CORP (Filer) CIK: 0001375623 (see all company filings)

IRS No.: 205322896 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52871 | Film No.: 091245548
SIC: 2836 Biological Products, (No Diagnostic Substances)